Producción CyT
Congreso
Autoría
MARTIN, AYELEN
;
Patricia, Pennisi
Fecha
2020
Editorial y Lugar de Edición
Springer Nature
Resumen
Información suministrada por el agente en
SIGEVA
The IGF system of ligands and receptors are known to play an important role in normal and neoplastic growth. Interestingly, in the past few years intact IGF1R has been detected in the nuclei of human cells, associating its presence with poor prognosis in several tumors. It has been described that IGF1R phosphorylation and subsequent SUMOylation of three conserved Lysins are required for its translocation. Central Nervous System (CNS) tumors are the most frequent solid tumors in pediatric popula...
The IGF system of ligands and receptors are known to play an important role in normal and neoplastic growth. Interestingly, in the past few years intact IGF1R has been detected in the nuclei of human cells, associating its presence with poor prognosis in several tumors. It has been described that IGF1R phosphorylation and subsequent SUMOylation of three conserved Lysins are required for its translocation. Central Nervous System (CNS) tumors are the most frequent solid tumors in pediatric population, being gliomas the most numerous groups. Due to the diference in their evolution and response to treatment, in clinical practice gliomas are divided in low-grade and high-grade tumors.Recently, we have shown that in pediatric gliomas, IGF1R nuclear localization was signifcantly associated with both high grade tumors and increased risk of death. In the present work, we studied the expression of IGFs ligands and receptors in a large cohort of pediatric patients with CNStumors. We found that, in gliomas, IGF1 expression is higherin high grade tumors. This result, in concordance with previous fndings, suggests that IGF1 signaling through IGF1R may be playing a role in the development of high-grade gliomas. To further explore the role of nuclear IGF1R inthese tumors we used U87MG human glioblastoma (GBM) cell line and transfected it with a vector containing wt IGF1R sequence (WtU87 cells) or a mutant form of IGF1R (IGF1R1025X1100X1120X) that avoid receptor´s sumoylation, hence IGF1R is not able to translocate to the nucleus (MutU87 cells). We used these two cell lines for in vitro and in vivo assays and found that in vitro IGF1R nuclear localization increased cell migration, glucose uptake and fatty acid biosynthesis, favoring phospholipid synthesis to TAG accumulation but had no efects on cell proliferation.In vivo, WtU87 cells developed earlier tumors that reached bigger volumes, suggesting that nuclear IGF1R contributes to a more aggressive phenotype. For children with glioblastomas (GBM), the main therapy after surgical resection is radiotherapy followed by chemotherapy using Temozolomide (TMZ). Even so, the best regimen of treatment stillneeds to be determined. Herein, we aimed to characterize GBM cell response to IGF1R inhibition by OSI906 alone or in combination with high or low doses of TMZ. We performed in vitro (proliferation assays) and in vivo (sc injection, nude male mice) treatments using OSI906, TMZ or the combination of both drugs, orally administered to the mice. Our results showed that only cells expressing the IGF1R with capacity to translocate to the nucleus were sensitive to OSI906 treatment, and showed synergic tumor growth inhibition in combination with low doses of TMZ (Figure T18).Therefore, IGF1R presence in the nuclei renders GBM cells sensitive to IGF1R targeted therapy alone or in combination with TMZ, both in vivo and in vitro. Taken together our results suggest that in pediatric patients with glioblastomas showing nuclear localization of IGF1R, the use of IGF1Rinhibitors, like OSI906 or others, could be useful to reduce TMZ doses and/or avoid radiotherapy specially in young children.
Ver más
Ver menos
Palabras Clave
Pediatric GliomaMetabolismnuclear IGF1R